GameChanger Media is changing the way amateur sports team communities collect, manage and consume information. We make software that helps teams be more efficient, informed, and connected.

Our mobile app and website provide scorekeeping, stats, live GameStream plays and recap stories for thousands of amateur teams.

GameChanger is free for coaches and scorekeepers. Our business is supported by parents and fans that purchase premium team content.

On 29 November 2016 the company was acquired by Dick’s Sporting Goods.

Parent Company
Dick's Sporting Goods
New York, US
GameChanger was founded in 2009 and is headquartered in New York, US

GameChanger Office Locations

GameChanger has an office in New York
New York, US (HQ)
202 86 Chambers St

GameChanger Data and Metrics

GameChanger Summary

In total, GameChanger had raised $10.6 m. GameChanger is a subsidiary of Dick's Sporting Goods

Traffic Overview of GameChanger

GameChanger Online and Social Media Presence

GameChanger News and Updates

Prostate cancer laser treatment could be a gamechanger for men

A drug that can kill cancerous cells without the side-effects of radical surgery is causing massive excitement for good reasonProstate has long been the Cinderella of cancers, lagging behind others – in particular breast cancer – when it comes to diagnosis, treatment and the funding that goes into r…

Dick’s Sporting Goods acquires mobile scorekeeping company GameChanger Media

 Dick’s Sporting Goods is expanding its digital tools with the acquisition of GameChanger Media, the company behind the mobile scorekeeping app of the same name. A sporting goods company (with 675 locations across the United States) might not seem like an obvious buyer of tech companies, but it’s be…

Immunotherapy drug a 'gamechanger' for head and neck cancer

Nivolumab found to extend lives of relapsed patients who had run out of therapy optionsAn immunotherapy drug hailed as a potential gamechanger in the treatment of cancer could soon offer new hope to patients with currently untreatable forms of the disease.Nivolumab was found to extend the lives of r…

Asthma drug 'gamechanger' could revolutionise treatment

Fevipiprant trial indicates it could halve patients’ risk of suffering asthma attacks and being admitted to hospitalA new asthma drug that could revolutionise the treatment of the 500,000 Britons with moderate or severe versions of the condition and reduce the number of deaths from has been hailed a…

GameChanger Company Life and Culture

You may also be interested in